Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid serum-saliva concentration correlation in critically ill patients with renal failure during CRRT
ChiCTR-OO-14004876Phase 4Recruiting
- Sponsor
- The 2nd Affiliated Hospital of Harbin Medical University
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of linezolid in Gram-positive bacterial infection, sponsored by The 2nd Affiliated Hospital of Harbin Medical University. Primary endpoints: Saliva linezolid concentration, Serum linezolid concentration and 1 more. Started Jul 2014; status: recruiting.
02
Drugs
linezolid
03
Conditions
Gram-positive bacterial infection
Beyond the preview
Go deeper on ChiCTR-OO-14004876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OO-14004876.